-
Mashup Score: 0Medtronic warns on previous software MiniMed 780G in Germany - 6 month(s) ago
Medtronic (NYSE:MDT) issued an urgent field safety notice in Germany to warn of a potential issue with its MiniMed 780G system.
Source: www.drugdeliverybusiness.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Insulin pump-makers grapple with questions about GLP-1s - 7 month(s) ago
The new class of weight loss drugs has caused a stock selloff, but is unlikely to “meaningfully change the long-term outlook for diabetes,” analysts wrote.
Source: www.medtechdive.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Analysts: GLP-1s should have minor impact on insulin pump market - 7 month(s) ago
Analysts are playing down the potentially negative impact of GLP-1 receptor agonists on the diabetes technology industry.
Source: www.drugdeliverybusiness.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The device, with a much smaller form than Tandem’s past pumps, could drive more people to switch from insulin injections, an analyst with Craig-Hallum said.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Tandem Diabetes Care (Nasdaq:TNDM) announced today that the FDA cleared its Tandem Mobi automated insulin delivery (AID) system.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Medtronic secures Medicare coverage for MiniMed 780G insulin pump - 9 month(s) ago
Medtronic has begun processing orders and will start shipping devices over the next few weeks.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Medtronic agrees to buy Korean insulin patch pump maker for $738m to boost diabetes business - 11 month(s) ago
The tubeless, disposable insulin patch made by EOFlow will be integrated into Medtronic’s MiniMed 780G system.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1FDA clears automated insulin pump from Beta Bionics for type 1 diabetes - 11 month(s) ago
The FDA announced today that it cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Embecta stock rises on Q2 results, raised full-year guidance - 11 month(s) ago
Embecta (Nasdaq:EMBC) shares ticked up today on second-quarter results that topped the consensus forecast, leading to a guidance increase.
Source: Drug Delivery BusinessCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump - 12 month(s) ago
Analysts called the FDA approval a “positive” for Medtronic that “should somewhat aid in a turnaround of its U.S. diabetes franchise.”
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
.@Medtronic warns on previous software #MiniMed780G in #Germany | #diabetes #insulinpump #artificialpancreas https://t.co/nRsstjFan8